Get 40% Off
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list

Novacyt (ALNOV)

Paris
Currency in EUR
Disclaimer
0.7140
+0.0840(+13.33%)
Closed

ALNOV Comments

I repeat this is a 1 dollar company
as much..don't waste your time here... move on
Good
Again
let's go
This is a 1 dollar company as much so don't waste your time here
Tomorrow it will be a 1 billion dollars company
You missed a very good opportunity
I repeat. this is a 1 dollar company as much
It looks like a perfect entry point, now!
That was definitely a good entry point 👍
Hopes to go to 12
Precious price to go! Signals give a chance
Novacyt is going to *******
what is happening?
Novacyt is future
Everybody is vaccinating, how can you say it's future?
1EUR company.
Pump & dump
let the whales comin in
The Dhsc extension contract is worth £100m. Yes it's a lot but I don't think it justifies £200m loss in market cap today for this news alone.
Anyone pleaase have a link to news regarding this crash? Thanks.
Contract brake with uk goverment
Thanks
Novacyt is finish
I thought it was British
no its french:)
Abandon Ship!
GAME OVER! NCYT TRYING TO SUE THE UK GOVERNEMNT.WHAT A BUNCH OF CRY BABIES
why it's falling?
I do not understand why it's going down. Time to buy more?
hope
what does it mean?
And although all that good news, stock is falling almost 15% down!!
https://novacyt.com/wp-content/uploads/2021/01/Novacyt-Trading-Update-29.01.2021-ENGLISH.pdf
COVID continue this year, so Novacyt will continue to grow.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.